AAAAAA

   
Results: 1-21 |
Results: 21
HIV PROTEASE GENOTYPE AND VIRAL SENSITIVITY TO HIV PROTEASE INHIBITORS FOLLOWING SAQUINAVIR THERAPY
Authors: CRAIG C RACE E SHELDON J WHITTAKER L GILBERT S MOFFATT A ROSE J DISSANAYEKE S CHIRN GW DUNCAN IB CAMMACK N
Citation: C. Craig et al., HIV PROTEASE GENOTYPE AND VIRAL SENSITIVITY TO HIV PROTEASE INHIBITORS FOLLOWING SAQUINAVIR THERAPY, AIDS, 12(13), 1998, pp. 1611-1618
CORRELATION OF RESPONSE TO TREATMENT AND HIV GENOTYPIC CHANGES DURINGPHASE-III TRIALS WITH SAQUINAVIR AND REVERSE-TRANSCRIPTASE INHIBITOR COMBINATION THERAPY
Authors: RACE E GILBERT SM SHELDON JG ROSE JSL MOFFATT AR SITBON G DISSANAYEKE SR CAMMACK N DUNCAN IB
Citation: E. Race et al., CORRELATION OF RESPONSE TO TREATMENT AND HIV GENOTYPIC CHANGES DURINGPHASE-III TRIALS WITH SAQUINAVIR AND REVERSE-TRANSCRIPTASE INHIBITOR COMBINATION THERAPY, AIDS, 12(12), 1998, pp. 1465-1474
HIV-1 FROM PATIENTS IN A PHASE-II CLINICAL-TRIAL WITH THE PROTEINASE-INHIBITOR (PI) SAQUINAVIR (SQV) TAKEN IN COMBINATION WITH RT INHIBITORS (RTIS) EXHIBITS VERY LITTLE REDUCED SENSITIVITY TO OTHER PIS
Authors: TOMLINSON PW CRAIG JC MOFFATT AR ROBERTS NA SHELDON JG WHITTAKER L DUNCAN IB
Citation: Pw. Tomlinson et al., HIV-1 FROM PATIENTS IN A PHASE-II CLINICAL-TRIAL WITH THE PROTEINASE-INHIBITOR (PI) SAQUINAVIR (SQV) TAKEN IN COMBINATION WITH RT INHIBITORS (RTIS) EXHIBITS VERY LITTLE REDUCED SENSITIVITY TO OTHER PIS, AIDS, 10, 1996, pp. 12-12
SAQUINAVIR (SQV) DOES NOT SELECT FOR UNIVERSAL CORESISTANCE WITH OTHER PROTEINASE-INHIBITORS (PI) IN PATIENTS
Authors: CRAIG C RACE E SHELDON J WHITTAKER L TOMLINSON PW MOFFAT A GILBERT S DUNCAN IB ROBERTS NA
Citation: C. Craig et al., SAQUINAVIR (SQV) DOES NOT SELECT FOR UNIVERSAL CORESISTANCE WITH OTHER PROTEINASE-INHIBITORS (PI) IN PATIENTS, AIDS, 10, 1996, pp. 13-13
LOW OCCURRENCE OF REDUCED SENSITIVITY TO SAQUINAVIR IN ANTIVIRAL COMBINATION - RESULTS FROM A PHASE-III CLINICAL-TRIAL (NV-14256)
Authors: RACE E GILBERT SM SHELDON JG MOFFAT AR TOMLINSON PW DUNCAN IB
Citation: E. Race et al., LOW OCCURRENCE OF REDUCED SENSITIVITY TO SAQUINAVIR IN ANTIVIRAL COMBINATION - RESULTS FROM A PHASE-III CLINICAL-TRIAL (NV-14256), AIDS, 10, 1996, pp. 15-15
CHANGES IN VIROLOGICAL MARKERS DURING PROLONGED SAQUINAVIR MONOTHERAPY
Authors: KAYE S PYM AS GALPIN S TEDDER RS WEBER JN DUNCAN IB
Citation: S. Kaye et al., CHANGES IN VIROLOGICAL MARKERS DURING PROLONGED SAQUINAVIR MONOTHERAPY, AIDS, 10, 1996, pp. 16-16
AN ASSESSMENT OF PHENOTYPIC AND GENOTYPIC CORESISTANCE TO INHIBITORS OF HIV PROTEINASE FOLLOWING THERAPY WITH HIGH-DOSE SAQUINAVIR
Authors: WHITTAKER L SCHAPIRO JM CRAIG JC WINTERS MA TOMLINSON PW SHELDON JG MOFFATT AR JACOBSEN H DUNCAN IB GILBERT S CRAWFORD S MERIGAN TC
Citation: L. Whittaker et al., AN ASSESSMENT OF PHENOTYPIC AND GENOTYPIC CORESISTANCE TO INHIBITORS OF HIV PROTEINASE FOLLOWING THERAPY WITH HIGH-DOSE SAQUINAVIR, AIDS, 10, 1996, pp. 17-17
AN OVERVIEW OF DRUG-RESISTANCE DURING SAQUINAVIR TREATMENT
Authors: RACE E GILBERT SM SHELDON JG MOFFAT AR TOMLINSON PW DUNCAN IB
Citation: E. Race et al., AN OVERVIEW OF DRUG-RESISTANCE DURING SAQUINAVIR TREATMENT, AIDS, 10, 1996, pp. 25-25
REDUCED SENSITIVITY TO SAQUINAVIR - AN UPDATE ON GENOTYPING FROM PHASE I II TRIALS/
Authors: JACOBSEN H HAENGGI M OTT M DUNCAN IB ANDREONI M VELLA S MOUS J
Citation: H. Jacobsen et al., REDUCED SENSITIVITY TO SAQUINAVIR - AN UPDATE ON GENOTYPING FROM PHASE I II TRIALS/, Antiviral research, 29(1), 1996, pp. 95-97
EFFICIENCY OF NANOPARTICLES AS A CARRIER SYSTEM FOR ANTIVIRAL AGENTS IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED HUMAN MONOCYTES MACROPHAGES IN-VITRO/
Authors: BENDER AR VONBRIESEN H KREUTER J DUNCAN IB RUBSAMENWAIGMANN H
Citation: Ar. Bender et al., EFFICIENCY OF NANOPARTICLES AS A CARRIER SYSTEM FOR ANTIVIRAL AGENTS IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED HUMAN MONOCYTES MACROPHAGES IN-VITRO/, Antimicrobial agents and chemotherapy, 40(6), 1996, pp. 1467-1471
IN-VIVO RESISTANCE TO A HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEINASE-INHIBITOR - MUTATIONS, KINETICS, AND FREQUENCIES
Authors: JACOBSEN H HANGGI M OTT M DUNCAN IB OWEN S ANDREONI M VELLA S MOUS J
Citation: H. Jacobsen et al., IN-VIVO RESISTANCE TO A HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEINASE-INHIBITOR - MUTATIONS, KINETICS, AND FREQUENCIES, The Journal of infectious diseases, 173(6), 1996, pp. 1379-1387
VIRAL LOAD AND CD4(- CORRELATION WITH THE EMERGENCE OF VIRAL ISOLATESWITH REDUCED SENSITIVITY() RESPONSES DURING COMBINATION THERAPY WITH ZIDOVUDINE AND SAQUINAVIR )
Authors: VELLA S BUTTO S FRANCO M OLIVETTA E TOMINO C GALLUZZO C GIANNINI G PIRILLO MF JACOBSEN H MOUS J DUNCAN IB SARMATI L ERCOLI L ANDREONI M
Citation: S. Vella et al., VIRAL LOAD AND CD4(- CORRELATION WITH THE EMERGENCE OF VIRAL ISOLATESWITH REDUCED SENSITIVITY() RESPONSES DURING COMBINATION THERAPY WITH ZIDOVUDINE AND SAQUINAVIR ), Journal of acquired immune deficiency syndromes and human retrovirology, 10, 1995, pp. 43-43
REDUCED SENSITIVITY TO SAQUINAVIR - AN UPDATE ON GENOTYPING FROM PHASE I II TRIALS/
Authors: JACOBSEN H HAENGGI M OTT M DUNCAN IB ANDREONI M VELLA S MOUS J
Citation: H. Jacobsen et al., REDUCED SENSITIVITY TO SAQUINAVIR - AN UPDATE ON GENOTYPING FROM PHASE I II TRIALS/, Journal of acquired immune deficiency syndromes and human retrovirology, 10, 1995, pp. 68-68
IN-VIVO RESISTANCE TO HIV PROTEINASE-INHIBITOR SAQUINAVIR - AN UPDATE
Authors: JACOBSEN H HAENGGI M OTT M DUNCAN IB VELLA S MOUS J
Citation: H. Jacobsen et al., IN-VIVO RESISTANCE TO HIV PROTEINASE-INHIBITOR SAQUINAVIR - AN UPDATE, AIDS research and human retroviruses, 11, 1995, pp. 169-169
SAFETY AND ACTIVITY OF SAQUINAVIR IN HIV-INFECTION
Authors: KITCHEN VS SKINNER C ARIYOSHI K LANE EA DUNCAN IB BURCKHARDT J BURGER HU BRAGMAN K PINCHING AJ WEBER JN
Citation: Vs. Kitchen et al., SAFETY AND ACTIVITY OF SAQUINAVIR IN HIV-INFECTION, Lancet, 345(8955), 1995, pp. 952-955
CHARACTERIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 MUTANTS WITH DECREASED SENSITIVITY TO PROTEINASE-INHIBITOR RO-31-8959
Authors: JACOBSEN H YASARGIL K WINSLOW DL CRAIG JC KROHN A DUNCAN IB MOUS J
Citation: H. Jacobsen et al., CHARACTERIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 MUTANTS WITH DECREASED SENSITIVITY TO PROTEINASE-INHIBITOR RO-31-8959, Virology, 206(1), 1995, pp. 527-534
IN-VITRO ANTI-HIV AND CYTOTOXICOLOGICAL EVALUATION OF THE TRIPLE COMBINATION - AZT AND DDC WITH HIV PROTEINASE-INHIBITOR SAQUINAVIR (RO-31-8959)
Authors: CRAIG JC WHITTAKER L DUNCAN IB ROBERTS NA
Citation: Jc. Craig et al., IN-VITRO ANTI-HIV AND CYTOTOXICOLOGICAL EVALUATION OF THE TRIPLE COMBINATION - AZT AND DDC WITH HIV PROTEINASE-INHIBITOR SAQUINAVIR (RO-31-8959), Antiviral chemistry & chemotherapy, 5(6), 1994, pp. 380-386
MOLECULAR CHARACTERIZATION OF HIV-VARIANTS WITH REDUCED SENSITIVITY TO RO-31-8959, A VIRAL PROTEINASE-INHIBITOR
Authors: JACOBSEN H CRAIG CJ DUNCAN IB HANGGI M YASARGIL K MOUS J
Citation: H. Jacobsen et al., MOLECULAR CHARACTERIZATION OF HIV-VARIANTS WITH REDUCED SENSITIVITY TO RO-31-8959, A VIRAL PROTEINASE-INHIBITOR, AIDS research and human retroviruses, 10, 1994, pp. 190000024-190000024
IN-VITRO RESISTANCE TO AN INHIBITOR OF HIV PROTEINASE (RO 31-8959) RELATIVE TO INHIBITORS OF REVERSE-TRANSCRIPTASE (AZT AND TIBO)
Authors: CRAIG JC WHITTAKER L DUNCAN IB ROBERTS NA
Citation: Jc. Craig et al., IN-VITRO RESISTANCE TO AN INHIBITOR OF HIV PROTEINASE (RO 31-8959) RELATIVE TO INHIBITORS OF REVERSE-TRANSCRIPTASE (AZT AND TIBO), Antiviral chemistry & chemotherapy, 4(6), 1993, pp. 335-339
ANTIVIRAL SYNERGY BETWEEN INHIBITORS OF HIV PROTEINASE AND REVERSE-TRANSCRIPTASE
Authors: CRAIG JC DUNCAN IB WHITTAKER L ROBERTS NA
Citation: Jc. Craig et al., ANTIVIRAL SYNERGY BETWEEN INHIBITORS OF HIV PROTEINASE AND REVERSE-TRANSCRIPTASE, Antiviral chemistry & chemotherapy, 4(3), 1993, pp. 161-166
CELL CULTURE-SELECTION AND CHARACTERIZATION OF VARIANT HIV-1 WITH REDUCED SENSITIVITY TO AN INHIBITOR OF THE VIRAL PROTEASE
Authors: JACOBSEN H CRAIG CJ DUNCAN IB KROHN A MOUS J YASARGIL K
Citation: H. Jacobsen et al., CELL CULTURE-SELECTION AND CHARACTERIZATION OF VARIANT HIV-1 WITH REDUCED SENSITIVITY TO AN INHIBITOR OF THE VIRAL PROTEASE, Journal of cellular biochemistry, 1993, pp. 90-90
Risultati: 1-21 |